首页> 外文期刊>Blood: The Journal of the American Society of Hematology >ITIM receptors: more than just inhibitors of platelet activation
【24h】

ITIM receptors: more than just inhibitors of platelet activation

机译:ITIM受体:不仅仅是血小板激活的抑制剂

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Since their discovery, immunoreceptor tyrosine-based inhibition motif (ITIM)-containing receptors have been shown to inhibit signaling from immunoreceptor tyrosine-based activation motif (ITAM)-containing receptors in almost all hematopoietic cells, including platelets. However, a growing body of evidence has emerged demonstrating that this is an oversimplification, and that ITIM-containing receptors are versatile regulators of platelet signal transduction, with functions beyond inhibiting ITAM-mediated platelet activation. PECAM-1 was the first ITIM-containing receptor identified in platelets and appeared to conform to the established model of ITIM-mediated attenuation of ITAM-driven activation. PECAM-1 was therefore widely accepted as a major negative regulator of platelet activation and thrombosis for many years, but more recent findings suggest a more complex role for this receptor, including the facilitation of alpha(IIb)beta(3)-mediated platelet functions. Since the identification of PECAM-1, several other ITIM-containing platelet receptors have been discovered. These include G6b-B, a critical regulator of platelet reactivity and production, and the noncanonical ITIM-containing receptor TREM-like transcript-1, which is localized to alpha-granules in resting platelets, binds fibrinogen, and acts as a positive regulator of platelet activation. Despite structural similarities and shared binding partners, including the Src homology 2 domain-containing protein-tyrosine phosphatases Shp1 and Shp2, knockout and transgenic mouse models have revealed distinct phenotypes and nonredundant functions for each ITIM-containing receptor in the context of platelet homeostasis. These roles are likely influenced by receptor density, compartmentalization, and as-yet unknown binding partners. In this review, we discuss the diverse repertoire of ITIM-containing receptors in platelets, highlighting intriguing new functions, controversies, and future areas of investigation.
机译:由于他们发现,已经证明了免疫受体酪氨酸的抑制基序(ITIM)抑制基序(ITIM)抑制受体抑制来自血管生成细胞几乎所有造血细胞中的免疫酪氨酸酪氨酸的活化基序(ITAM)的受体中的信号传导,包括血小板。然而,出现了越来越多的证据表明这是一种过度简化,含ITIM的受体是血小板信号转导的通用调节因子,其功能超出抑制ITAM介导的血小板活化。 PECAM-1是血小板中鉴定的第一个含ITIM受体,并且似乎符合ITIM驱动激活的ITIM介导的衰减的建立模型。因此,PECAM-1被广泛接受为血小板活化和血栓形成多年的主要负调节剂,但最近的发现表明该受体的作用更复杂,包括α(IIB)β(3)介导的血小板功能的促进。由于PECAM-1的鉴定,已经发现了几种其他含有含有血小板受体。这些包括G6B-B,血小板反应性和生产的临界调节剂,以及含有非甘露吞的ITIM的受体TRMB样转录物-1,其局限于静止血小板中的α-颗粒,结合纤维蛋白原,并作为阳性调节器血小板激活。尽管具有结构性相似之处和共享结合伴侣,但包括SRC同源性2结构域的蛋白质 - 酪氨酸SHP1和SHP2,敲除和转基因小鼠模型在血小板稳态的背景下揭示了含有ITIM的受体的明显表型和非冗余功能。这些作用可能受到受体密度,卧室化和尚未有未知的结合伴侣的影响。在这篇综述中,我们讨论了血小板中含有ITIM的受体的多样化曲目,突出了有趣的新功能,争议和未来的调查领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号